Skip to main content
Bluvy Tube
Press Esc to exit fullscreen
Volume m
/
i
Theater mode t
f
/
Retatrutide, a new GLP agonist, blunts appetite, boosts fat burning, and improves metabolic rate for unheard-of weight loss. AOD-9604 mobilizes fatty acids, Tesamorelin reduces dangerous visceral fat. For focus, Semax increases BDNF for plasticity, while Dihexa is millions of times more potent.

Keyboard shortcuts

Space K
Play / pause
← →
Back / forward 5 s
J L
Back / forward 10 s
0–9
Jump to 0%–90% of the video
Home End
Start / end
, .
Previous / next frame (while paused)
< >
Slower / faster
↑ ↓
Volume
M
Mute / unmute
C
Captions
F
Fullscreen
I
Picture-in-picture
T
Theater mode
?
Show this help

Retatrutide, a new GLP agonist, blunts appetite, boosts fat burning, and improves metabolic rate for unheard-of weight loss. AOD-9604 mobilizes fatty acids, Tesamorelin reduces dangerous visceral fat. For focus, Semax increases BDNF for plasticity, while Dihexa is millions of times more potent.

Biohacking Concept

Biohacking Concept

@oldmanclipper.bsky.social

Subscribe
0 views Published on 17/10/2026 15:57 0:58
Retatrutide, a new GLP agonist, blunts appetite, boosts fat burning, and improves metabolic rate for unheard-of weight loss. AOD-9604 mobilizes fatty acids, Tesamorelin reduces dangerous visceral fat. For focus, Semax increases BDNF for plasticity, while Dihexa is millions of times more potent.
0 comments
?
No comments yet. Be the first to react!
View original post on Bluesky
Link copied to clipboard

Sign in

Time to take a break

You've been watching videos for 30 minutes straight: give yourself 5 minutes away from the screen. Stand up, stretch, grab a glass of water… Your videos will be right here when you're back.